Evaluation of 846 Liver Transplant Patients Infected with COVID-19 in Turkey

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL
Yusuf Yavuz, H. Durgut
{"title":"Evaluation of 846 Liver Transplant Patients Infected with COVID-19 in Turkey","authors":"Yusuf Yavuz, H. Durgut","doi":"10.4274/bmj.galenos.2022.2022.3-17","DOIUrl":null,"url":null,"abstract":"Objective: The clinical course of coronavirus infection in liver transplant patients is not known accurately. The aim of this study was to examine the epidemiological incidence and outcomes of liver transplant patients after coronavirus disease-2019 (COVID-19) infection who have been registered in the data system of the Tissue, Organ Transplant and Dialysis Services Department. Methods: In this study, which was designed non-interventional, retrospective, and observational;the demographic information, clinical and radiological parameters, lifetime, hospital service and intensive care requirements and length of stay of the patients who were recorded in the information systems of the Ministry of Health, have were examined. A total of 3,426 liver transplant patients who were admitted to the hospital with suspected COVID-19 in Turkey between April 2020 and April 2021 were included in the study. Results: Between April 2020-April 2021, 3,426 cases of liver transplant who admitted to hospitals with symptoms of COVID-19 infection in Turkey were examined. The ratio of patients diagnosed with COVID-19 infection was 24.69% (846), with a mean age of 52.3%. The 13.48% (462 people) of 3,426 people who had liver transplants were hospitalized. The mean age of the hospitalized patients was 46.6, and the average length of hospital stay was 8.64 days. When the thorax computed tomography scans of 3,426 people with suspected COVID-19 and liver transplant were examined, pneumonia was detected in 344 (10%) people and they were treated as an inpatient. The mean age of the patients with pneumonia was 59 years. The number of liver transplant patients who died was 108 (3.1%), with a mean age of 65 years. The ratio of followup in the intensive care unit for organ transplant recipients was 0.32%, and 0.26% of them were intubated patients. Conclusion: Despite the use of immunosuppressive drugs in patients with liver transplant, the requirement for intensive care and the length of stay in the intensive care unit was found to be low, and the importance of strict follow-up and treatment in such patients was recognized once again.","PeriodicalId":42529,"journal":{"name":"Medical Journal of Bakirkoy","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Bakirkoy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/bmj.galenos.2022.2022.3-17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: The clinical course of coronavirus infection in liver transplant patients is not known accurately. The aim of this study was to examine the epidemiological incidence and outcomes of liver transplant patients after coronavirus disease-2019 (COVID-19) infection who have been registered in the data system of the Tissue, Organ Transplant and Dialysis Services Department. Methods: In this study, which was designed non-interventional, retrospective, and observational;the demographic information, clinical and radiological parameters, lifetime, hospital service and intensive care requirements and length of stay of the patients who were recorded in the information systems of the Ministry of Health, have were examined. A total of 3,426 liver transplant patients who were admitted to the hospital with suspected COVID-19 in Turkey between April 2020 and April 2021 were included in the study. Results: Between April 2020-April 2021, 3,426 cases of liver transplant who admitted to hospitals with symptoms of COVID-19 infection in Turkey were examined. The ratio of patients diagnosed with COVID-19 infection was 24.69% (846), with a mean age of 52.3%. The 13.48% (462 people) of 3,426 people who had liver transplants were hospitalized. The mean age of the hospitalized patients was 46.6, and the average length of hospital stay was 8.64 days. When the thorax computed tomography scans of 3,426 people with suspected COVID-19 and liver transplant were examined, pneumonia was detected in 344 (10%) people and they were treated as an inpatient. The mean age of the patients with pneumonia was 59 years. The number of liver transplant patients who died was 108 (3.1%), with a mean age of 65 years. The ratio of followup in the intensive care unit for organ transplant recipients was 0.32%, and 0.26% of them were intubated patients. Conclusion: Despite the use of immunosuppressive drugs in patients with liver transplant, the requirement for intensive care and the length of stay in the intensive care unit was found to be low, and the importance of strict follow-up and treatment in such patients was recognized once again.
土耳其846例肝移植患者感染新冠肺炎的评估
目的:肝移植患者冠状病毒感染的临床过程尚不清楚。本研究的目的是检查组织、器官移植和透析服务部数据系统中登记的2019冠状病毒病(新冠肺炎)感染后肝移植患者的流行病学发病率和结果。方法:本研究采用非介入性、回顾性、观察性研究方法;对卫生部信息系统中记录的患者的人口统计信息、临床和放射学参数、寿命、医院服务和重症监护要求以及住院时间进行了检查。2020年4月至2021年4月期间,土耳其共有3426名疑似新冠肺炎肝移植患者入院接受研究。结果:在2020年4月至2021年4月期间,土耳其有3426例因新冠肺炎感染症状入院的肝移植病例接受了检查。诊断为新冠肺炎感染的患者比例为24.69%(846人),平均年龄为52.3%。3426名接受肝移植的患者中,13.48%(462人)住院治疗。住院患者的平均年龄为46.6岁,平均住院时间为8.64天。当对3426名疑似新冠肺炎患者和肝移植患者进行胸部计算机断层扫描检查时,344人(10%)被检测出肺炎,并接受住院治疗。肺炎患者的平均年龄为59岁。肝移植患者死亡人数为108人(3.1%),平均年龄65岁。器官移植受者在重症监护室的随访率为0.32%,其中0.26%为插管患者。结论:尽管肝移植患者使用了免疫抑制药物,但对重症监护的要求和在重症监护室的停留时间都很低,并且再次认识到对此类患者进行严格随访和治疗的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Journal of Bakirkoy
Medical Journal of Bakirkoy MEDICINE, GENERAL & INTERNAL-
CiteScore
0.20
自引率
0.00%
发文量
58
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信